The prevalence and causes of anemia in the elderly have been studied in 142 individuals aged 60-99 in a small rural community in which a high prevalence of nutritional anemia in pregnancy and childhood has been previously shown. The mean hemoglobin levels of elderly patients were significantly lower than those of the control groups of younger individuals and the prevalence of anemia increased with age. However, the reduction of hemoglobin was slight and in only 2% of the subjects studied has an anemia of less than 10 g/dl been found. The mild reduction of hemoglobin in the elderly population was paralleled by a slight, but significant reduction in serum iron, red cell folates and serum vitamin B12, and a slight increase in TIBC. Therapeutic trial with folic acid failed to improve hemoglobin levels but iron therapy resulted in an increase of at least 1 g/dl in about half of the patients with less than 13 g initial hemoglobin. In the rest of the patients who failed to respond to either folate or iron therapy, anemia was most probably the consequence of underlying chronic disorders where inflammation and renal insufficiency might have been the mechanism responsible for reduced hemoglobin levels. The relatively low prevalence and the mildness of nutritional anemia in the elderly, as opposed to the high prevalence and the severity of anemia in children and pregnant women in the same community, seems to support the contention that increased demand, rather than limited supply is the main factor responsible for the development of nutritional anemia.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.